Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study

Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study

Abstract Background Endometrial cancer is closely linked to obesity and type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally developed for diabetes, demonstrate potential anti-cancer properties. This study aims to investigate the association between SGLT2i...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Wang, Mingxia Ye, Maria Lucero, Wanchun Pan, Xin Wang, Heping Zhang, Ling Zhou, Yuanguang Meng
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Sodium-glucose cotransporter-2 inhibitor
Endometrial cancer
Mortality
Online Access:https://doi.org/10.1186/s12885-025-14453-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14453-w

Similar Items